Joonyoung Cho
Research Subjects
Joonyoung Cho has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Hyeyoon Chang
Deep Bio Inc
2 shared publications - Sun Woo Kim
Deep Bio Inc., Seoul 08380, Republic of Korea
2 shared publications - Tae-Yeong Kwak
Deep Bio Inc
2 shared publications - Byeong Jin Kang
Department of Urology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Republic of Korea
1 shared publication - Chan Ho Lee
Department of Urology, Busan Paik Hospital, Inje University College of Medicine, Busan 47392, Republic of Korea
1 shared publication - Chan Kwon Jung
Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea
1 shared publication
Latest Publications
- Open Access
- 31 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Clinical implications of deep learning based image analysis of whole radical prostatectomy specimens
Prostate cancer (PCa) diagnosis faces significant challenges due to its complex pathological characteristics and insufficient pathologist resources. While deep learning-based image analysis (DLIA) shows promise in enhancing diagnostic accuracy, its application to radical prostatectomy (RP) specimens remains underexplored. In this study, we evaluated the clinical feasibility and prognostic value of a DLIA algorithm for Gleason grading and tumor quantification on whole RP specimens. Using 29,646 digitized H&E-stained slides from 992 patients who underwent RP, we compared the case-level algorithm results with pathologist assessments for the International Society of Urological Pathology grade groups (GG), tumor volumes (TV), and percent tumor volumes (PTV). We also evaluated their prognostic performance in predicting biochemical progression-free survival (BPFS). Pathologists identified cancer in 986 cases and assigned GG in 980, while the DLIA algorithm identified cancer and assigned GG to all cases without omission. DLIA-assigned GG showed fair concordance with pathologist assessments (linear-weighted Cohen’s kappa: 0.374) and demonstrated similar efficacy in predicting BPFS (c-index: 0.644 for DLIA vs. 0.654 for pathologists; p = 0.52). In tumor quantification, DLIA-measured TV and PTV were strongly correlated with pathologist-based measurements (Pearson’s correlation coefficient: 0.830 and 0.846, respectively), but showed stronger efficacy in BPFS prediction, with c-index values of 0.657 and 0.672 compared to 0.622 and 0.641, respectively. Incorporating DLIA-derived PTV into the CAPRA-S score significantly improved its predictive accuracy for BCR (p = 0.006), increasing the c-index from 0.704 to 0.715. Our findings indicate that DLIA algorithms can enhance the accuracy of Gleason grading and tumor quantification in RP specimens, providing valuable support in clinical decision-making for PCa management.
- 31 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Open AccessClinical implications of deep learning based image analysis of whole radical prostatectomy specimens
Prostate cancer (PCa) diagnosis faces significant challenges due to its complex pathological characteristics and insufficient pathologist resources. While deep learning-based image analysis (DLIA) shows promise in enhancing diagnostic accuracy, its application to radical prostatectomy (RP) specimens remains underexplored. In this study, we evaluated the clinical feasibility and prognostic value of a DLIA algorithm for Gleason grading and tumor quantification on whole RP specimens. Using 29,646 digitized H&E-stained slides from 992 patients who underwent RP, we compared the case-level algorithm results with pathologist assessments for the International Society of Urological Pathology grade groups (GG), tumor volumes (TV), and percent tumor volumes (PTV). We also evaluated their prognostic performance in predicting biochemical progression-free survival (BPFS). Pathologists identified cancer in 986 cases and assigned GG in 980, while the DLIA algorithm identified cancer and assigned GG to all cases without omission. DLIA-assigned GG showed fair concordance with pathologist assessments (linear-weighted Cohen’s kappa: 0.374) and demonstrated similar efficacy in predicting BPFS (c-index: 0.644 for DLIA vs. 0.654 for pathologists; p = 0.52). In tumor quantification, DLIA-measured TV and PTV were strongly correlated with pathologist-based measurements (Pearson’s correlation coefficient: 0.830 and 0.846, respectively), but showed stronger efficacy in BPFS prediction, with c-index values of 0.657 and 0.672 compared to 0.622 and 0.641, respectively. Incorporating DLIA-derived PTV into the CAPRA-S score significantly improved its predictive accuracy for BCR (p = 0.006), increasing the c-index from 0.704 to 0.715. Our findings indicate that DLIA algorithms can enhance the accuracy of Gleason grading and tumor quantification in RP specimens, providing valuable support in clinical decision-making for PCa management.
- Open Access
- 15 January 2019
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 53 (1) , 1-12
Artificial Intelligence in Pathology
As in other domains, artificial intelligence is becoming increasingly important in medicine. In particular,deep learning-based pattern recognition methods can advance the field of pathology byincorporating clinical, radiologic, and genomic data to accurately diagnose diseases and predictpatient prognoses. In this review, we present an overview of artificial intelligence, the brief historyof artificial intelligence in the medical domain, recent advances in artificial intelligence applied topathology, and future prospects of pathology driven by artificial intelligence.
- 15 January 2019
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 53 (1) , 1-12
Open AccessArtificial Intelligence in Pathology
As in other domains, artificial intelligence is becoming increasingly important in medicine. In particular,deep learning-based pattern recognition methods can advance the field of pathology byincorporating clinical, radiologic, and genomic data to accurately diagnose diseases and predictpatient prognoses. In this review, we present an overview of artificial intelligence, the brief historyof artificial intelligence in the medical domain, recent advances in artificial intelligence applied topathology, and future prospects of pathology driven by artificial intelligence.